Stage IV/Recurrent Esophageal Cancer

Depression May Persist With Metastatic Cancer (05-27-2010)

A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.[1] While... Continue Reading

Xeloda® and Eloxatin® Evaluated in Esophageal and Gastric Cancers (03-8-2009)

Xeloda® and Eloxatin® Evaluated in Esophageal and Gastric Cancers According to the results of a Phase III clinical trial published in the New England Journal of Medicine, it may be possible to replace 5-FU (5-fluorouracil) with Xeloda® (capecitabine)... Continue Reading

« Previous Page